- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06970977
CRS Questionnaire Validation Study for Chronic Rhinosinusitis Patients
The CRS Questionnaire Validation Project aims to develop and validate new diagnostic tools for assessing chronic rhinosinusitis (CRS) patients' condition severity and disease control. This observational study will evaluate two novel questionnaires against established measurement tools like SNOT-22 and VAS scores in a large cohort of 1,000 adult patients across Europe.
Key objectives of this research include:
- Creating validated questionnaires specifically designed to capture CRS patients' perceived disease status
- Testing the new tools in routine clinical practice settings
- Comparing results with existing diagnostic standards (EPOS criteria)
- Establishing potential new gold standards for CRS assessment
Conducted by The European Forum for Research and Education in Allergy and Airway Diseases, the study focuses on adult patients with physician-confirmed CRS (with or without nasal polyps) who haven't had recent sinus surgery. Participants will complete a comprehensive set of questionnaires during a single visit, eliminating the need for follow-up appointments.
The research methodology involves:
- Patient-reported outcome measures through multiple validated tools
- Statistical analysis comparing new and established questionnaires
- Language-specific validation across participating centers
- Correlation analysis between different measurement systems
This large-scale validation project addresses critical gaps in CRS assessment by developing patient-centered measurement tools that better reflect the real-world impact of chronic sinusitis. The results may significantly improve clinical decision-making and treatment evaluation for this prevalent chronic condition affecting millions worldwide.
Study outcomes will be analyzed after reaching the enrollment target of 1,000 participants, with final results expected by mid-2025. The research represents an important step toward standardizing CRS evaluation across European healthcare systems while maintaining focus on patient-reported experiences and symptoms.
Upcoming Clinical Trials
-
NCT07826949Not yet recruitingGlioma | Brain Neoplasm | Recurrent High-Grade Gliomas
-
NCT07826962Not yet recruiting
-
NCT07826975Not yet recruiting
-
NCT07826988Not yet recruitingSickle Cell Disease | Vaso-occlusive Crisis
-
NCT07827001RecruitingBrain Cancer | CNS Cancer | Nervous System Cancer | Brain Cancer Metastatic
-
NCT07827027Not yet recruiting
-
NCT07827040RecruitingAdults | Low Vision Digital Assistance | Visual Impairments
-
NCT07827053Not yet recruitingPancreatic Ductal Adenocarcinoma (PDAC)
-
NCT07827066Not yet recruitingSmoking Cessation | AI Agent | Early-Stage Cancer
-
NCT07827131Not yet recruiting